Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.
MacLeod M, Papi A, Contoli M, Beghé B, Celli BR, Wedzicha JA, Fabbri LM.
Respirology. 2021 Jun;26(6):532-551. doi: 10.1111/resp.14041. Epub 2021 Apr 24.
Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Ruan H, Zhang H, Wang J, Zhao H, Han W, Li J.
Respir Med. 2023 Jan;206:107090. doi: 10.1016/j.rmed.2022.107090. Epub 2022 Dec 13.
Heart failure promotes multimorbidity through innate immune memory.
Nakayama Y, Fujiu K, Oshima T, Matsuda J, Sugita J, Matsubara TJ, Liu Y, Goto K, Kani K, Uchida R, Takeda N, Morita H, Xiao Y, Hayashi M, Maru Y, Hasumi E, Kojima T, Ishiguro S, Kijima Y, Yachie N, Yamazaki S, Yamamoto R, Kudo F, Nakanishi M, Iwama A, Fujiki R, Kaneda A, Ohara O, Nagai R, Manabe I, Komuro I.
Sci Immunol. 2024 May 24;9(95):eade3814. doi: 10.1126/sciimmunol.ade3814. Epub 2024 May 24.
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
Graul EL, Nordon C, Rhodes K, Marshall J, Menon S, Kallis C, Ioannides AE, Whittaker HR, Peters NS, Quint JK.
Am J Respir Crit Care Med. 2024 Apr 15;209(8):960-972. doi: 10.1164/rccm.202307-1122OC.
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease.
Roca M, Verduri A, Corbetta L, Clini E, Fabbri LM, Beghé B.
Eur J Clin Invest. 2013 May;43(5):510-21. doi: 10.1111/eci.12064. Epub 2013 Mar 12.
Dyspnea.
Shiber JR, Santana J.
Med Clin North Am. 2006 May;90(3):453-79. doi: 10.1016/j.mcna.2005.11.006.
Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
Zhao X, Su R, Hu R, Chen Y, Xu X, Yuan Y, Zhang J, Zhang W, Yang Y, Chen M, Li D, Wu B, Huang D, Wu D.
BMC Geriatr. 2023 Feb 11;23(1):89. doi: 10.1186/s12877-023-03784-7.
Discharge planning and resource utilization for minimizing readmissions in acute exacerbation of chronic heart failure: Insights from an observational study in a community hospital.
Abouzid MR, Siddiqi M.
Curr Probl Cardiol. 2024 Feb;49(2):102197. doi: 10.1016/j.cpcardiol.2023.102197. Epub 2023 Nov 15.
Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary Disease.
Taniguchi A, Miyahara N, Oda N, Morichika D, Ichihara E, Oze I, Tanimoto Y, Ichikawa H, Fujii U, Tanimoto M, Kanehiro A, Kiura K.
Acta Med Okayama. 2017 Oct;71(5):453-457. doi: 10.18926/AMO/55446.
ANTXR1 blockade enhances cardiac function in preclinical models of heart failure.
Boccella N, Yu G, Seaman S, Feng Y, Lee J, Tomassoni-Ardori F, Yang L, Hsu KS, Dunleavey JM, Becker J, Hilton MB, Morris K, Borchin N, So D, Bajgain P, Yanpallewar S, Gross RT, Dewan KC, Bowles DE, Yuen DA, Tessarollo L, St Croix B.
Nat Cardiovasc Res. 2025 Nov;4(11):1521-1538. doi: 10.1038/s44161-025-00725-y. Epub 2025 Oct 2.
